Ursula Klause

Direttore Tecnico/Scientifico/R&S presso BIOPORTO A/S

Health Technology

Consumer Services

Profilo

Ursula Klause is currently the Vice President-Research & Development at Bioporto A since 2020.
Previously, she worked as a Manager-Senior Scientific Affairs at Roche Diagnostics Corp.
Dr. Klause holds a doctorate degree from Universität zu Köln and a graduate degree from the University of Bonn.

Posizioni attive di Ursula Klause

Società	Posizione	Inizio
BIOPORTO A/S	Direttore Tecnico/Scientifico/R&S	01/12/2020

Tutte le posizioni attive di Ursula Klause

Precedenti posizioni note di Ursula Klause

Società	Posizione	Fine
Roche Diagnostics Corp. Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Ursula Klause

Formazione di Ursula Klause

University of Bonn	Graduate Degree
Universität zu Köln	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ursula Klause

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BIOPORTO A/S	Health Technology

Aziende private	1
Roche Diagnostics Corp. Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.	Health Technology